Closing HIV Workforce Gaps Through Advanced Practice Providers and Pharmacist Integration
Abstract The United States continues to face a mismatch between demand for HIV prevention and care and the supply of
Our Experience Developing the HIV Physician Workforce
As Program Director of the Kaiser Permanente Northern California HIV Medicine Fellowship, I am delighted to share our experience in
Changes to Florida’s ADAP Are Impacting the HIV Workforce
In our Ryan White-funded clinics, we are nothing if not adaptable and efficient. As a pharmacist in a safety net
When HIV Funding and Workforce Falter, Patients Pay the Price
HIV care in the United States is one of medicine’s most impressive success stories. In the darkest days of the
Building the HIV Workforce Pipeline: Practical Strategies to Attract the Next Generation
When I recently spoke with Dr. Amanda Allmacher, AAHIVE, about the future of the HIV workforce, our conversation quickly became
Letter from the Director – Summer 2026
I’d like to welcome you to the first fully digital issue of the quarterly HIV Specialist. This all-new digital format
FDA Approves Drug to Treat HIV Infection in Newborns
The U.S. Food and Drug Administration (FDA) has approved Tivicay PD tablets for oral suspension (dolutegravir) to treat HIV infection
Virtual intervention reduces substance use in American Indians and Alaska Natives
Emerging adults who participated in workshops combining evidence-based interventions and traditional practices reported reduced cannabis, alcohol use, and anxiety. A
New Regulation Prohibits Federal Medicaid Funds From Covering Gender-Affirming Medical Care for Young People
On August 11, 2026, the Centers for Medicare and Medicaid Services (CMS) issued a much-anticipated final rule prohibiting federal Medicaid or Children’s
Study Shows LGBTQ+ Youth in the U.S. Face High Rates of Suicidality and Victimization, Worsened by Anti-LGBTQ+ Politics
May 6, 2026 — The Trevor Project, the leading suicide prevention and crisis intervention organization for LGBTQ+ young people, released The 2025
Clinical Research Update – Summer 2026
Featured Literature McCrary LM, Curtis MR, Kelly JC, et al. Real-world experience of hepatitis C treatment with glecaprevir-pibrentasvir during pregnancy.